- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03368885
Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI
Evaluation of Integrating Selected MIYCN Interventions in Existing Polio Eradication Platform of Project Concern International (PCI) in UP
Study Overview
Status
Conditions
Detailed Description
The experimental arm will receive the following interventions:
- Interpersonal communication (IPC) to reach target women (Women in their 2nd or 3rd trimester of pregnancy and women with 6-23 months old child) to deliver messages on maternal nutrition package and complementary feeding through home visits made by Community Mobilization Coordinator (CMC).
- Expanded community mobilization involving key influencers in family like husbands and mothers -in-law and community opinion leaders, religious leaders, Village Health Sanitation and Nutrition Committee (VHSNC) members. The aims are to improve awareness, shift norms and perceptions, engage husbands and local opinion leaders to promote healthy behaviour practices related to maternal nutrition and complementary feeding.
- Strategic use of data to design a context-specific program and track the progress of the program with regards to impact on social norms and behaviors at household/community level and demonstrate the feasibility of integrating select MIYCN interventions in polio eradication platforms.
- Convergence: The convergence will mainly focus on three Cs - maintain consistency, avoid conflict and enhance cooperation. This will aid in passing consistent MIYCN messages to the target community and ensure effective teamwork, collaboration and mutual support
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110001
- FHI Solutions LLC, Alive & Thrive
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
For Community
• Women aged 15-49 years
- Willing and able to provide consent
- Women in 2nd and 3rd trimester of pregnancy and / or
- Women with children aged 6-23 months For CMC
- Women aged 18+
- Currently appointed a CMC in a selected HRA
- Willing and able to provide consent
Exclusion Criteria:
- Women in first trimester of pregnancy
- Women whose index child (youngest child, between 6-23 months of age) is not her biological child
- Women whose index child is not currently living with the mother
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental area PCI
In this arm, in addition to the standard care for Polio eradication program activities of CGPP project, the following interventions are added: Maternal dietary diversity; Diet diversity in complementary feeding; Exclusive breast feeding; Community mobilization; Capacity building; Convergence;Use of existing platforms VHSND; Strategic Use of Data |
Counsel pregnant women for proper dietary intake and create awareness among family members and community to support her on maternal nutrition
Counsel mothers of children of 6-23 months on diet diversity in complementary feeding by demonstration during home-visits and seek support from father and family members
Counselling on exclusive breast feeding among children under 6 months-Provide information to mothers of children of 3-6 months for exclusive breast feeding through home visits, and mothers meetings
Engagement of local/religious leader, husbands to support diet diversity for pregnant women and doctors and fathers to support diet diversity for complementary feeding
Capacity Building-Training of Community mobilization coordinator and mentoring for knowledge enhancement on nutrition for pregnant women and children below 2 years
Convergence- Strengthen Village Health Sanitation and Nutrition Day for creating awareness on diet diversity for maternal nutrition and complementary feeding
Strategic use of data-Data analysis for concurrent monitoring,planning and decision making to improve the performance of CMCs
|
|
No Intervention: Control area PCI
This arm will receive standard care with respect to Polio eradication program activities of CGPP such as awareness generation around Polio and routine immunization, hand washing and sanitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary Diversity in Maternal Nutrition
Time Frame: 12 months
|
Percentage of Women in their 2nd or 3rd trimester of pregnancy from targeted households who consumed food from at least 5 specific nutrient rich food groups out of 10 defined food groups.
|
12 months
|
|
Minimum Dietary Diversity in Complementary Feeding
Time Frame: 12 months
|
Percentage of children 6-23 months of age from targeted households who receive foods from 4 or more food groups (separately for breastfed and non-breastfed children)
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timely Introduction of Complementary Feeding
Time Frame: 12 months
|
Percentage of children 6-23 months of age who were initiated with complementary feeding in their seventh month.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Preeti Das, MPS, FHI 360
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1101870
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polio
-
International Centre for Diarrhoeal Disease Research...Not yet recruiting
-
Instituto Nacional de Saúde, MozambiqueWorld Health OrganizationCompleted
-
Zhejiang Provincial Center for Disease Control...China National Biotec Group Company LimitedCompleted
-
Stanford UniversityBill and Melinda Gates Foundation; Instituto Nacional de Salud Publica, MexicoCompleted
-
Vaxtrials S.A.Bill and Melinda Gates FoundationCompleted
-
Hadassah Medical OrganizationCompletedActivity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio PatientsPost-polio SyndromeIsrael
-
Instituto Grifols, S.A.TerminatedPost-polio SyndromeUnited States, Denmark, Spain, Germany, Poland, Canada, Czechia, Italy, Netherlands
-
University Hospital, Basel, SwitzerlandUniversity Children's Hospital BaselUnknown
-
Aga Khan UniversityBill and Melinda Gates Foundation; World Health Organization; UNICEF; Peshawar... and other collaboratorsUnknownPolio | Polio Sero Conversion | Polio Sero Prevalence | Immunization CoveragePakistan
Clinical Trials on Maternal dietary diversity
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Centers for Disease Control and PreventionCompleted
-
Colorado State UniversityUniversity of Colorado, Denver; University of UtahRecruitingPTSD - Post Traumatic Stress DisorderUnited States
-
Pennington Biomedical Research CenterRecruitingBreast NeoplasmsUnited States
-
St George's, University of LondonMU-JHU CARE; Biomedical Research and Training Institute, ZimbabweRecruitingNeonatal SepsisUganda, United Kingdom
-
Women and Infants Hospital of Rhode IslandRecruitingLabor Complication | Cesarean Delivery Affecting Fetus | Labor DystociaUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedAutism Spectrum Disorder | Gut -Microbiota | Neurodevelopment OutcomeTurkey
-
National Yang Ming UniversityRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteUniversity of BarcelonaUnknownPersistent Occiput Posterior Position During LaborSpain
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); American Society of Clinical OncologyActive, not recruiting